Press Releases

Featured Press Releases

Support of "TRIPS" Waiver Sets Dangerous…

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), released the following statement in response to the White House's support of waiving critical intellectual property rights for COVID-19…

Learn more

Global “SHARE” Program for COVID could provide…

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Joe Biden yesterday suggesting the establishment of a COVID Global Strategy for Harnessing Access Reaching Everyone (SHARE)…

Learn more

BIO DIGITAL 2021 TO FEATURE WHO’s WHO IN PUBLIC…

Former CNN anchor Brooke Baldwin welcomes an all-star lineup including Albert Bourla, Francis Collins, Jennifer Doudna, Anthony Fauci, Sanjay Gupta, Richard Haass, Janet Woodcock, and a host of industry leaders

Learn more

Support of "TRIPS" Waiver Sets Dangerous Precedent

May 5, 2021

Global “SHARE” Program for COVID could provide global protection against pandemic and create American jobs

May 4, 2021

BIO DIGITAL 2021 TO FEATURE WHO’s WHO IN PUBLIC HEALTH

May 3, 2021

BIO's Dr. Michelle McMurry-Heath Comments on Passage of Washington State's Clean Fuel Standard

April 26, 2021

BIO President and CEO Dr. Michelle McMurry-Heath issued the following statement following the passage of a clean fuel standard bill (HB 1091) in Washington state. "With the passage of HB 1091, Washington state is showing once again that climate…

H.R. 3 To Handicap Future Medical Innovation, Destroy Hope for Vulnerable Patients

April 23, 2021

Following the re-introduction of the H.R. 3 drug pricing legislation, Rich Masters -- Chief Public Affairs and Advocacy Officer of the Biotechnology Innovation Organization (BIO) -- made the following remarks: "On behalf of BIO’s…

Proposed “TRIPS” Waiver Is the WRONG Way To Attack Global Access for Vaccines to Developing Countries

April 20, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), yesterday sent a letter to U.S. Trade Representative (USTR) Ambassador Katherine Tai sharing BIO perspectives regarding the proposed WTO “TRIPS waiver”…

BIO Welcomes Collaboration With New HHS, USTR Leaders

March 18, 2021

The Biotechnology Innovation Organization (BIO) welcomes the confirmations this week of Katherine Tai to the position of U.S. Trade Representative (USTR) and Xavier Becerra to lead the Department of Health and Human Services (HHS). The United…

New Mexico's Clean Fuel Standard Will Ignite State's Green Economy

March 11, 2021

Albuquerque, NM (March 11, 2021) — Today, the Biotechnology Innovation Organization (BIO) released the following statement applauding the passage of a clean fuel standard in New Mexico: “The passage of a clean fuel standard in New Mexico…

BIO responds to Congress' Covid-19 relief package

March 10, 2021

Today, Congress passed the “American Rescue Plan” – a $1.9 trillion coronavirus relief package aimed at alleviating some of the economic and health impacts of the COVID-19 pandemic. Upon passage of the bill, Dr. Michelle McMurry-Heath, president…

Letter to President Biden Discusses Collaboration To Boost Access to COVID-19 Treatments

March 8, 2021

Dr. Michelle McMurry-Heath, president and CEO of the Biotechnology Innovation Organization (BIO), sent a letter to President Biden outlining ways the public and private sectors can best work with global partners to ensure that patients around the…

Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy.